Rigel Q3 revenue rises to $80.9 million as net income falls to $13.2 million
Rigel reported third quarter 2026 total revenues of $80.9 million, up from $69.5 million a year earlier, driven by net product sales of $72.3 million, including $6.6 million from newly launched VEPPANU. Net income fell to $13.2 million, or $0.65 per diluted share, from $27.9 million, or $1.46 per diluted share, as costs and expenses rose to $63.8 million from $41.0 million. The company raised its 2026 total revenue guidance at the low end, to $290 to $295 million, but lowered its net product sales range to $255 to $260 million.
Key points
- Q3 2026 total revenues $80.9 million vs. $69.5 million in Q3 2025; net product sales up 13%
- Q3 2026 net income $13.2 million ($0.65 diluted per share) vs. $27.9 million ($1.46) a year earlier
- 2026 total revenue guidance raised to $290 to $295 million from $285 to $295 million; net product sales guidance lowered to $255 to $260 million from $255 to $265 million
- VEPPANU became commercially available August 13, 2026; cash and short-term investments were $99.3 million at September 30, 2026
The filing
Written by AI on Nov 9, 2026, 8:29 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on November 05, 2026.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.